These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7080994)

  • 1. Immunologic study of carcinoma of the digestive tract. Effects of the tumor stage. I. Cellular immunity in the preoperative period.
    Sanz ML; Subirá ML; Oehling A; Hernández JL; Zornoza G
    Allergol Immunopathol (Madr); 1982; 10(1):33-42. PubMed ID: 7080994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of the lymphocytic and oncofetal antigen subpopulations in patients with adenocarcinomas of the stomach and of the colon and rectum (author's transl)].
    Voltas J; Sanz ML; Hernández JL; Crisci CD; Subirá ML; Zornoza G
    Med Clin (Barc); 1979 Dec; 73(10):419-23. PubMed ID: 93670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic study of carcinoma of the digestive tract. Influence of tumor staging. II. Humoral immunity in the preoperative period.
    Sanz ML; Oehling A; Subirá ML; Hernández JL; Lera JM; Zornoza G
    Allergol Immunopathol (Madr); 1982; 10(2):95-100. PubMed ID: 7102489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subpopulations in colo-rectal cancer. Preoperative evaluation.
    Hernández JL; Sanz ML; Crisci CD; Voltas J; Subirá ML; Zornoza G; Oehling A
    Allergol Immunopathol (Madr); 1978; 6(4):339-44. PubMed ID: 310638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro studies of autologous and allogeneic recognition in patients with gastric and colorectal adenocarcinoma].
    Machado I; Cabrera L; Anderson C; Meilijson O; Pérez L; Bianco N
    G E N; 1985; 39(1):1-19. PubMed ID: 2939005
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of lymphocyte-mediated cytotoxicity after tumor resection in patients with colorectal cancer.
    Waller CA; Gill PG; MacLennan IC
    J Natl Cancer Inst; 1980 Aug; 65(2):223-30. PubMed ID: 6931244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular immunity indices in rectal cancer under surgical and combined treatment].
    Evsev'eva AI; Mosienko MD; Zybina MA; Umanskiĭ IuA
    Vopr Onkol; 1981; 27(6):40-4. PubMed ID: 7269416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
    Karanikas V; Hwang LA; Pearson J; Ong CS; Apostolopoulos V; Vaughan H; Xing PX; Jamieson G; Pietersz G; Tait B; Broadbent R; Thynne G; McKenzie IF
    J Clin Invest; 1997 Dec; 100(11):2783-92. PubMed ID: 9389743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
    Muhrer KH; Kahle M; Pasurka B
    Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some immunologic characteristics of carcinoma of the colon and rectum.
    Elias EG; Elias LL
    Surg Gynecol Obstet; 1975 Nov; 141(5):715-8. PubMed ID: 1198304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subpopulations in gastric cancer. Preoperative evaluation.
    Sanz ML; Crisci CD; Hernández JL; Subirá ML; Voltas J; Zornoza G; Oehling A
    Allergol Immunopathol (Madr); 1978; 6(5):415-22. PubMed ID: 311148
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro cell-mediated immune reactivity in colon cancer patients.
    Markova R; Argirova R; Boeva M
    Neoplasma; 1982; 29(5):567-72. PubMed ID: 7177246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some parameters of cell-mediated immunity in colon cancer patients.
    Markova R; Argirova R; Boeva M
    Neoplasma; 1980; 27(1):43-6. PubMed ID: 6966380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of cytotoxicity of lymphocyte populations in coloncarcinoma patients in comparison to normal controls using a new statistical method of evaluation.
    Warnatz H; Eder E; Lackner D; Hommel G
    Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):128-42. PubMed ID: 906620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skin sensitization of costus root oil and peripheral lymphocyte count in gastric and colon cancers].
    Takanami I; Utsunomiya T; Ohnishi H; Shinohara H; Bessho T; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):81-6. PubMed ID: 6696456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human peritoneal immune cells in early stages of gastric and colon cancer.
    Olszewski WL; Kubicka U; Tarnowski W; Bielecki K; Ziolkowska A; Wesolowska A
    Surgery; 2007 Feb; 141(2):212-21. PubMed ID: 17263978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status of T-system immunity in patients with chronic diseases and cancer of the gastrointestinal tract].
    Movsesian KS; Voĭtenkov BO; Mel'nikov RA; Evtiukhin AI; Stefanenko IuF
    Vopr Onkol; 1985; 31(1):60-3. PubMed ID: 3871990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune reactivity in colorectal cancer--clinical value from a surgical viewpoint].
    Muhrer KH; Schwemmle K; Filler D; Kahle M
    Chirurg; 1982 Feb; 53(2):112-6. PubMed ID: 7075339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased monocyte phagocytosis and decreased lymphocyte mitogen reactivity in colorectal cancer patients.
    Ruco LP; Procopio A; Valtieri M; Uccini S; Chirletti P; Baroni CD
    Appl Pathol; 1983; 1(3):149-56. PubMed ID: 6678592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.